AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33025678 — intervention group
Group type: COMPARATOR
Intervention: Knockdown of LINC01089
Number of subjects: 2
Study 33025678 — intervention group
Group type: EXPERIMENTAL
Intervention: LINC01089
Number of subjects: 2
Study 32077737 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooperation After Divorce online intervention platform
Number of subjects: 1856
Study 32077737 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1856
Study 35303068 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracoscopic oesophagectomy
Number of subjects: 2250
Study 35303068 — intervention group
Group type: COMPARATOR
Intervention: Open oesophagectomy
Number of subjects: 2250
Study 33689966 — intervention group
Group type: EXPERIMENTAL
Intervention: Attribution Questionnaire‐Substance Use Disorder (AQ‐SUD)
Number of subjects: 304
Study 33689966 — intervention group
Group type: EXPERIMENTAL
Intervention: Other public stigma scales
Number of subjects: 304
Study 33689966 — intervention group
Group type: COMPARATOR
Intervention: Marijuana use disorder vignette
Number of subjects: 304
Study 35801306 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooperative Learning (CL)
Number of subjects: 1890
Study 33693968 — intervention group
Group type: EXPERIMENTAL
Intervention: WhyperGAN
Number of subjects: 150
Study 33693968 — intervention group
Group type: COMPARATOR
Intervention: H-DenseUnet
Number of subjects: 150
Study 32558287 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote patient management (RPM)
Number of subjects: 1537
Study 32558287 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 1537
Study 32558287 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC) in SR patients
Number of subjects: 1537
Study 32558287 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote patient management (RPM) in SR patients
Number of subjects: 1537
Study 32558287 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote patient management (RPM) in AF patients
Number of subjects: 1537
Study 32558287 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC) in AF patients
Number of subjects: 1537
Study 35012535 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time research ethics approach (RTREA)
Number of subjects: 0
Study 33290108 — intervention group
Group type: EXPERIMENTAL
Intervention: Dashboard driven infliximab dosing (precision group, PG)
Number of subjects: 80
Study 33290108 — intervention group
Group type: COMPARATOR
Intervention: Standard infliximab dosing (control group, CG)
Number of subjects: 80
Study 35131978 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance training added to physical therapy
Number of subjects: 42
Study 35131978 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy (control group)
Number of subjects: 42
Study 34226072 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care ultrasound (POCUS)
Number of subjects: 256
Study 34226072 — intervention group
Group type: COMPARATOR
Intervention: Radiology-performed ultrasound (RADUS)
Number of subjects: 256
Study 36440473 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost analysis of pump to CMM
Number of subjects: 54
Study 36440473 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal compounded medications
Number of subjects: 54
Study 33843980 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized PEEP (median 18 cm H2O)
Number of subjects: 90
Study 33843980 — intervention group
Group type: COMPARATOR
Intervention: Fixed PEEP of 12 cm H2O
Number of subjects: 90
Study 33843980 — intervention group
Group type: COMPARATOR
Intervention: Fixed PEEP of 4 to 5 cm H2O
Number of subjects: 90
Study 35595676 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 1787
Study 35595676 — intervention group
Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 1787
Study 35595676 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-stent technique in PCI
Number of subjects: 1787
Study 33346899 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface treatment group (intraoperative spraying and drug-soaked gauze covering the wound combined with local injection into the articular cavity)
Number of subjects: 102
Study 33346899 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface treatment group
Number of subjects: 102
Study 33346899 — intervention group
Group type: COMPARATOR
Intervention: Control group (TXA by intravenous drip combined with local injection into the articular cavity)
Number of subjects: 102
Study 33346899 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 102
Study 33607509 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated cognitive‐behavioral therapy
Number of subjects: 111
Study 33607509 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 111
Study 33607509 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher baseline parental monitoring
Number of subjects: 111
Study 33607509 — intervention group
Group type: EXPERIMENTAL
Intervention: Family functioning domains (family roles and affective involvement)
Number of subjects: 111
Study 33370736 — intervention group
Group type: EXPERIMENTAL
Intervention: Information support method combined with yoga exercise (60 minutes, three times a week for 24 weeks)
Number of subjects: 106
Study 33370736 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 106
Study 36382708 — intervention group
Group type: EXPERIMENTAL
Intervention: Implant supported fixed dental prosthesis
Number of subjects: 86000
Study 36382708 — intervention group
Group type: COMPARATOR
Intervention: Implant supported overdentures
Number of subjects: 86000
Study 32380889 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐17A rs2275913 A/A genotype
Number of subjects: 320
Study 32380889 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐17A A allele
Number of subjects: 320
Study 32380889 — intervention group
Group type: COMPARATOR
Intervention: IL‐17A rs8193036 and rs3748067 SNPs
Number of subjects: 320
Study 34963211 — intervention group
Group type: EXPERIMENTAL
Intervention: HUPPP plus radiofrequency ablation of tongue base
Number of subjects: 43
Study 34963211 — intervention group
Group type: COMPARATOR
Intervention: HUPPP plus traction of tongue base
Number of subjects: 43
Study 34963211 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Ablation and Traction)
Number of subjects: 43
Study 34917038 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 30
Study 34917038 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 34917038 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison between groups
Number of subjects: 30
Study 33043354 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass fiber post
Number of subjects: 150
Study 33043354 — intervention group
Group type: COMPARATOR
Intervention: Metal post
Number of subjects: 150
Study 35999630 — intervention group
Group type: EXPERIMENTAL
Intervention: Danshao Shugan Granules (DSSG)
Number of subjects: 260
Study 35999630 — intervention group
Group type: COMPARATOR
Intervention: Silibinin
Number of subjects: 260
Study 35999630 — intervention group
Group type: COMPARATOR
Intervention: Rosiglitazone
Number of subjects: 260
Study 35999630 — intervention group
Group type: EXPERIMENTAL
Intervention: DSSG (in murine model)
Number of subjects: 260
Study 35102969 — intervention group
Group type: EXPERIMENTAL
Intervention: Strip crowns
Number of subjects: 24
Study 35102969 — intervention group
Group type: EXPERIMENTAL
Intervention: Preformed primary anterior zirconia crowns
Number of subjects: 24
Study 35177621 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccination followed by Tdap-IPV 3 months later
Number of subjects: 0
Study 35177621 — intervention group
Group type: COMPARATOR
Intervention: BCG + Tdap-IPV concurrently
Number of subjects: 0
Study 35177621 — intervention group
Group type: COMPARATOR
Intervention: Tdap-IPV followed by BCG 3 months later
Number of subjects: 0
Study 32150549 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly healthy lean donor FMT capsules for 6 weeks
Number of subjects: 24
Study 32150549 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules for 6 weeks
Number of subjects: 24
Study 33938071 — intervention group
Group type: EXPERIMENTAL
Intervention: Active group (HDM immunotherapy)
Number of subjects: 182
Study 33938071 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 182
Study 33938071 — intervention group
Group type: EXPERIMENTAL
Intervention: Active group (HDM immunotherapy) in younger individuals (16-30 years)
Number of subjects: 182
Study 33938071 — intervention group
Group type: COMPARATOR
Intervention: Placebo group in younger individuals (16-30 years)
Number of subjects: 182
Study 32895353 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra articular Hyaluronic acid injections weekly for three weeks
Number of subjects: 70
Study 32895353 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 40 milligrams orally daily for 6 months
Number of subjects: 70
Study 36942062 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin 60 mg daily
Number of subjects: 60
Study 36942062 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin 40 mg daily (Control)
Number of subjects: 60
Study 36136263 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic umbilical cord blood-derived mesenchymal stem cells (hUCB-MSC) with sodium hyaluronate
Number of subjects: 0
Study 36136263 — intervention group
Group type: COMPARATOR
Intervention: Microfracture treatment
Number of subjects: 0
Study 33323326 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive individualized nutrition counseling (3 monthly sessions)
Number of subjects: 59
Study 33323326 — intervention group
Group type: COMPARATOR
Intervention: Control group (one-time group program)
Number of subjects: 59
Study 36422170 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper-extremity Biodex balance training program (3 times/week for 8 weeks)
Number of subjects: 50
Study 36422170 — intervention group
Group type: COMPARATOR
Intervention: Regular weightlifting training routine (control group)
Number of subjects: 50
Study 36422170 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper-extremity Biodex balance training program
Number of subjects: 50
Study 36481752 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet interventions for alcohol use disorders
Number of subjects: 0
Study 33452173 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous Abatacept (SC ABA)
Number of subjects: 343
Study 33452173 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous Abatacept (IV ABA)
Number of subjects: 343
Study 33452173 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant use of methotrexate and glucocorticoids with ABA
Number of subjects: 343
Study 33452173 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (both SC and IV ABA)
Number of subjects: 343
Study 32823200 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg nicotine gum
Number of subjects: 0
Study 32823200 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg nicotine gum
Number of subjects: 0
Study 32823200 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32823200 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy smokers
Number of subjects: 0
Study 35170742 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab
Number of subjects: 0
Study 35170742 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34379777 — intervention group
Group type: EXPERIMENTAL
Intervention: Error-Augmentation Training (EAT)
Number of subjects: 54
Study 34379777 — intervention group
Group type: EXPERIMENTAL
Intervention: Error-Correction Training (ECT)
Number of subjects: 54
Study 34379777 — intervention group
Group type: COMPARATOR
Intervention: Supervised Walking (CTL)
Number of subjects: 54
Study 35742573 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for cannabis cessation (CBT-CC)
Number of subjects: 65
Study 35742573 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 65
Study 34022825 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular exercises
Number of subjects: 0
Study 34022825 — intervention group
Group type: COMPARATOR
Intervention: Quadriceps exercises
Number of subjects: 0
Study 32564557 — intervention group
Group type: EXPERIMENTAL
Intervention: A1762T/G1764A double mutations in HBV DNA
Number of subjects: 39
Study 32564557 — intervention group
Group type: COMPARATOR
Intervention: Control group (mothers without intrauterine transmission)
Number of subjects: 39
Study 34906745 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted CRC screening intervention including health literacy-directed counseling, simplified materials, motivational interviewing, and motivational reminder messages.
Number of subjects: 1200
Study 34906745 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (EUC) arm receiving standard follow-up provided by their clinic or colonoscopy facility.
Number of subjects: 1200
Study 34453620 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-low tidal volume ventilation (3 ml/kg predicted body weight)
Number of subjects: 17
Study 34453620 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation (6 ml/kg predicted body weight)
Number of subjects: 17
Study 32997421 — intervention group
Group type: EXPERIMENTAL
Intervention: Group ZZ (tooth brushing)
Number of subjects: 33
Study 32997421 — intervention group
Group type: EXPERIMENTAL
Intervention: Group ZZS (tooth brushing and mouth rinsing)
Number of subjects: 33
Study 32997421 — intervention group
Group type: EXPERIMENTAL
Intervention: Group ZZSS (tooth brushing, mouth rinsing, and additional miniature toothbrush)
Number of subjects: 33
Study 35238225 — intervention group
Group type: EXPERIMENTAL
Intervention: D-yogurt (500 mL/day, fortified with 1000 IU of vitamin D)
Number of subjects: 135
Study 35238225 — intervention group
Group type: EXPERIMENTAL
Intervention: D-bread (50 g/day, fortified with 1000 IU of vitamin D)
Number of subjects: 135
Study 35238225 — intervention group
Group type: EXPERIMENTAL
Intervention: D-supplement (1000 IU vitamin D)
Number of subjects: 135
Study 35238225 — intervention group
Group type: COMPARATOR
Intervention: P-yogurt (500 mL/day, plain yogurt)
Number of subjects: 135
Study 35238225 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study 34289828 — intervention group
Group type: EXPERIMENTAL
Intervention: MiLES intervention (web-based intervention for employers)
Number of subjects: 35
Study 34289828 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 35
Study 32104687 — intervention group
Group type: EXPERIMENTAL
Intervention: LHTLH (Living High-Training Low)
Number of subjects: 19
Study 32104687 — intervention group
Group type: COMPARATOR
Intervention: Normoxic training group (NG)
Number of subjects: 19
Study 34991940 — intervention group
Group type: EXPERIMENTAL
Intervention: Patellar resurfacing (PR)
Number of subjects: 50
Study 34991940 — intervention group
Group type: COMPARATOR
Intervention: Non-patellar resurfacing (non-PR)
Number of subjects: 50
Study 33475663 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymethoxyflavone purified from Kaempferia parviflora (12 mg per day for 12 weeks)
Number of subjects: 80
Study 33475663 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 32783338 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodentine + ultrasonic activation
Number of subjects: 60
Study 32783338 — intervention group
Group type: COMPARATOR
Intervention: Biodentine + hand condensation
Number of subjects: 60
Study 32783338 — intervention group
Group type: EXPERIMENTAL
Intervention: NeoMTA Plus + ultrasonic activation
Number of subjects: 60
Study 32783338 — intervention group
Group type: COMPARATOR
Intervention: NeoMTA Plus + hand condensation
Number of subjects: 60
Study 32783338 — intervention group
Group type: EXPERIMENTAL
Intervention: ProRoot WMTA + ultrasonic activation
Number of subjects: 60
Study 32783338 — intervention group
Group type: COMPARATOR
Intervention: ProRoot WMTA + hand condensation
Number of subjects: 60
Study 35233508 — intervention group
Group type: EXPERIMENTAL
Intervention: G-chemotherapy
Number of subjects: 195
Study 35233508 — intervention group
Group type: COMPARATOR
Intervention: R-chemotherapy
Number of subjects: 195
Study 32289325 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Energy Density (LED) preload: 1.00 kcal/g; 100 kcal
Number of subjects: 212
Study 32289325 — intervention group
Group type: COMPARATOR
Intervention: High Energy Density (HED) preload: 1.60 kcal/g; 160 kcal
Number of subjects: 212
Study 35957963 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with placebo
Number of subjects: 96
Study 35957963 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture combined with medication
Number of subjects: 96
Study 32661644 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombocytopenia in subgroup B2 (IVH − PHH)
Number of subjects: 180
Study 32661644 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombocytopenia in subgroup B1 (IVH + PHH)
Number of subjects: 180
Study 32661644 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of IVH grades in subgroup B1 (IVH + PHH)
Number of subjects: 180
Study 32661644 — intervention group
Group type: COMPARATOR
Intervention: Thrombocytopenia and development of PHH
Number of subjects: 180
Study 33357465 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1 g bolus, followed by continuous infusion of 1 g every 8 h, terminated immediately before aneurysm treatment, or 24 h after start of the medication)
Number of subjects: 955
Study 33357465 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 955
Study 33357465 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 955
Study 33051038 — intervention group
Group type: EXPERIMENTAL
Intervention: Unified Protocol (UP)
Number of subjects: 179
Study 33051038 — intervention group
Group type: COMPARATOR
Intervention: Single-Disorder Protocol (SDP)
Number of subjects: 179
Study 35417317 — intervention group
Group type: EXPERIMENTAL
Intervention: WhatsApp Midwife Breastfeeding Support Line counseling and support for two months
Number of subjects: 100
Study 35417317 — intervention group
Group type: COMPARATOR
Intervention: Control group (no WhatsApp support)
Number of subjects: 100
Study 35881513 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-hour fasting group (n = 116)
Number of subjects: 227
Study 35881513 — intervention group
Group type: COMPARATOR
Intervention: 2-hour fasting group (n = 111)
Number of subjects: 227
Study 35881513 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 227
Study 33879015 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic intravenous fluid (sodium chloride, 0.9%, and dextrose, 5%)
Number of subjects: 60
Study 33879015 — intervention group
Group type: COMPARATOR
Intervention: Hypotonic intravenous fluid (sodium chloride, 0.15%, and dextrose, 5%)
Number of subjects: 60
Study 32788396 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 2 mg
Number of subjects: 3492
Study 32788396 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg
Number of subjects: 3492
Study 32788396 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3492
Study 32788396 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib (all doses)
Number of subjects: 3492
Study 35717008 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote Ischemic Preconditioning (RIPC) applied in 50% (n=60) of patients
Number of subjects: 120
Study 35717008 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote Ischemic Preconditioning (RIPC)
Number of subjects: 120
Study 32134754 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixation time of 96 hours with SP142 antibody
Number of subjects: 0
Study 32134754 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixation time of 96 hours with SP263 antibody
Number of subjects: 0
Study 32134754 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixation times ranging from 12 to 72 hours
Number of subjects: 0
Study 32134754 — intervention group
Group type: EXPERIMENTAL
Intervention: SP142 antibody after 96 hours of fixation
Number of subjects: 0
Study 32134754 — intervention group
Group type: EXPERIMENTAL
Intervention: SP263 antibody after 96 hours of fixation
Number of subjects: 0
Study 33031478 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher adherence to Mediterranean Diet (PREDIMED score >7)
Number of subjects: 309
Study 34242396 — intervention group
Group type: EXPERIMENTAL
Intervention: Case management plus treatment as usual
Number of subjects: 172
Study 34242396 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 172
Study 34142567 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic seawater spray containing chamomile liquid extract (Group A)
Number of subjects: 123
Study 34142567 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic seawater spray (Group B)
Number of subjects: 123
Study 34142567 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic seawater nasal irrigation (Group C)
Number of subjects: 123
Study 34142567 — intervention group
Group type: COMPARATOR
Intervention: Nasal steroid spray without nasal washing treatment (Group D)
Number of subjects: 123
Study 34102371 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing intervention program (education support and patient monitoring)
Number of subjects: 143
Study 34102371 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 143
Study 34102371 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing intervention program
Number of subjects: 143
Study 35819445 — intervention group
Group type: EXPERIMENTAL
Intervention: Liberal transfusion thresholds
Number of subjects: 0
Study 35819445 — intervention group
Group type: COMPARATOR
Intervention: Restrictive transfusion thresholds
Number of subjects: 0
Study 34307701 — intervention group
Group type: EXPERIMENTAL
Intervention: Video Laryngoscopy (VDL)
Number of subjects: 158
Study 34307701 — intervention group
Group type: COMPARATOR
Intervention: Direct Laryngoscopy (DL)
Number of subjects: 158
Study 34982322 — intervention group
Group type: EXPERIMENTAL
Intervention: Hilotherapy
Number of subjects: 62
Study 34982322 — intervention group
Group type: COMPARATOR
Intervention: Frozen gloves
Number of subjects: 62
Study 34672949 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon beta‐1a plus remdesivir
Number of subjects: 969